VIM-AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2-mediated HMGCS1 mRNA stabilization

VIM-AS1, a cancer-specific long non-coding RNA, has been recognized as a pivotal regulator in multiple types of cancer. However, the role of VIM-AS1 in the proliferation and resistance to anti-androgen therapy of LNCaP and C4-2 prostate cancer cells remains to be determined. In the current study, ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Sheng-Jia, Han, Dong-Hui, Zhang, Jing-Liang, Li, Yu, Yang, An-Gang, Zhang, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911078/
https://www.ncbi.nlm.nih.gov/pubmed/36734275
http://dx.doi.org/10.3892/ijo.2023.5482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911078/
https://www.ncbi.nlm.nih.gov/pubmed/36734275
http://dx.doi.org/10.3892/ijo.2023.5482

Ejemplares similares